ClinConnect ClinConnect Logo
Search / Trial NCT03146689

Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis?

Launched by UNIVERSITY OF NOTTINGHAM · May 5, 2017

Trial Information

Current as of May 15, 2025

Completed

Keywords

Osteoarthritis N Of 1 Ibuprofen Capsaicin Nsaid Topical

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and non-pregnant women who have had ultrasound and radiographic assessments in the Knee Pain in the Community study
  • o Premenopausal women will need to be on an acceptable contraceptive method
  • Aged 40-95 years
  • Knee pain between 4-8 on the NRS
  • Knee osteoarthritis - defined as knee pain plus radiographic changes, based on previous questionnaire responses and radiographic findings
  • Knee pain: individuals with knee pain in and around the knee on most days for at least a month.
  • Radiographic changes: definite joint space narrowing and definite osteophytes (each scoring two or more on the Nottingham Line Drawing Atlas) in the tibiofemoral and/or patellofemoral compartments
  • Predominantly neuropathic or inflammatory phenotypes based on previous questionnaire responses (not current status)
  • Predominantly neuropathic phenotype: painDETECT Questionnaire (PDQ) \> 13 and synovial hypertrophy (SH) \<4 mm
  • Predominantly inflammatory phenotype: SH \> 4 mm and PDQ \< 13
  • If we cannot recruit enough people with the above thresholds, we will base recruitment on the overall distribution of PDQ and SH scores from the population. The third tertile of PDQ and the first tertile of SH for neuropathic and the first tertile of PDQ and the third tertile of SH for inflammatory phenotypes.
  • Exclusion Criteria:
  • Inability to give informed consent
  • Daily use of oral NSAIDs for the last two weeks
  • Prior use of Ibuprofen gel or Zacin on the affected knee(s)
  • Terminal or untreated major mental illness
  • Pregnancy or breastfeeding
  • Hypersensitivity or allergy to topical NSAIDs, capsaicin, or other ingredients in the preparations. This includes individuals that experience attacks of asthma, urticaria, or acute rhinitis that are precipitated by NSAIDs
  • Current treatment for stomach or duodenal ulcers
  • Total joint replacement of affected joint
  • Renal failure
  • Taking anticoagulants

About University Of Nottingham

The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.

Locations

Nottingham, Nottinghamshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Weiya Zhang, PhD

Principal Investigator

University of Nottingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials